In a stunning display of results-driven leadership, President Trump's TrumpRx.gov initiative scored a major political and economic victory as billionaire entrepreneur Mark Cuban publicly endorsed the platform at a high-profile White House event. Cuban, whose Cost Plus Drugs company supplies 559 of the over 600 generic medications listed on the site, made clear that the partnership is already delivering real results — and promises to deliver even more. "As our volumes go up, our costs go down, which means we'll be ending up charging less to people over a period of time," Cuban declared, adding, "This is a special partnership... we're really excited to be part of this." It is the kind of bold, private-sector collaboration that the Trump administration has championed from day one, delivering concrete relief to everyday Americans crushed by Big Pharma's stranglehold on drug pricing.